Literature DB >> 33302435

Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma.

Tjorge Maaßen1, Siranush Vardanyan1, Anton Brosig1, Hartmut Merz2, Mahdy Ranjbar1, Vinodh Kakkassery1, Salvatore Grisanti1, Aysegül Tura1.   

Abstract

Monosomy-3 in uveal melanoma (UM) cells increases the risk of fatal metastases. The gene encoding the low-affinity glucose transporter GLUT2 resides on chromosome 3q26.2. Here, we analyzed the expression of the glucose transporters GLUT1, GLUT2, and GLUT3 with regard to the histological and clinical factors by performing immunohistochemistry on the primary tumors of n = 33 UM patients. UMs with monosomy-3 exhibited a 57% lower immunoreactivity for GLUT2 and a 1.8×-fold higher ratio of GLUT1 to total GLUT1-3. The combined levels of GLUT1-3 proteins were reduced in the irradiated but not the non-irradiated tumors with monosomy-3. GLUT3 expression was stronger in the irradiated samples with disomy-3 versus monosomy-3, but the ratio of the GLUT3 isoform to total GLUT1-3 did not differ with regard to the monosomy-3 status in the irradiated or non-irradiated subgroups. Systemic metastases were associated with the presence of monosomy-3 in the primary and circulating tumor cells as well as a higher GLUT1 ratio. Upregulation of the high-affinity glucose transporter GLUT1 possibly as a compensation for the low-affinity isoform GLUT2 may be enhancing the basal glucose uptake in the UM cells with monosomy-3. Prevention of hyperglycemia might, therefore, be a valuable approach to delay the lethal UM metastases.

Entities:  

Keywords:  GLUT1; GLUT2; GLUT3; glucose transport; monosomy-3; uveal melanoma

Year:  2020        PMID: 33302435      PMCID: PMC7762573          DOI: 10.3390/ijms21249345

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  75 in total

1.  Mapping the human liver/islet glucose transporter (GLUT2) gene within a genetic linkage map of chromosome 3q using a (CA)n dinucleotide repeat polymorphism and characterization of the polymorphism in three racial groups.

Authors:  A Matsutani; A Hing; T Steinbrueck; R Janssen; J Weber; M A Permutt; H Donis-Keller
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

2.  Mannose impairs tumour growth and enhances chemotherapy.

Authors:  Pablo Sierra Gonzalez; James O'Prey; Simone Cardaci; Valentin J A Barthet; Jun-Ichi Sakamaki; Florian Beaumatin; Antonia Roseweir; David M Gay; Gillian Mackay; Gaurav Malviya; Elżbieta Kania; Shona Ritchie; Alice D Baudot; Barbara Zunino; Agata Mrowinska; Colin Nixon; Darren Ennis; Aoisha Hoyle; David Millan; Iain A McNeish; Owen J Sansom; Joanne Edwards; Kevin M Ryan
Journal:  Nature       Date:  2018-11-21       Impact factor: 49.962

3.  Expression of P53 protein in primary uveal melanoma.

Authors:  S Sulkowski; M Sulkowska; W Famulski; L Chyczewski; A Bakunowicz-Lazarczyk
Journal:  Folia Histochem Cytobiol       Date:  2001       Impact factor: 1.698

4.  The impact of N- and O-glycosylation on the functions of Glut-1 transporter in human thyroid anaplastic cells.

Authors:  Nezha Samih; Sonia Hovsepian; Frédéric Notel; Maëlle Prorok; Hélène Zattara-Cannoni; Sylvie Mathieu; Dominique Lombardo; Guy Fayet; Assou El-Battari
Journal:  Biochim Biophys Acta       Date:  2003-04-07

5.  Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.

Authors:  Laleh G Melstrom; Mohammad R Salabat; Xian-Zhong Ding; Benjamin M Milam; Matthew Strouch; Jill C Pelling; David J Bentrem
Journal:  Pancreas       Date:  2008-11       Impact factor: 3.327

6.  Association of positive dual-modality positron emission tomography/computed tomography imaging of primary choroidal melanoma with chromosome 3 loss and tumor size.

Authors:  Tara A McCannel; Shantan Reddy; Barry L Burgess; Martin Auerbach
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

7.  Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4.

Authors:  Christophe Montessuit; Nathalie Rosenblatt-Velin; Irène Papageorgiou; Lis Campos; Corinne Pellieux; Tatiana Palma; René Lerch
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

8.  Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.

Authors:  Fa-Xing Yu; Jing Luo; Jung-Soon Mo; Guangbo Liu; Young Chul Kim; Zhipeng Meng; Ling Zhao; Gholam Peyman; Hong Ouyang; Wei Jiang; Jiagang Zhao; Xu Chen; Liangfang Zhang; Cun-Yu Wang; Boris C Bastian; Kang Zhang; Kun-Liang Guan
Journal:  Cancer Cell       Date:  2014-05-29       Impact factor: 31.743

9.  Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).

Authors:  Mary E Aronow; Allan K Topham; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2017-10-13

Review 10.  Glucose transporter 1 in health and disease.

Authors:  Sindhuri Pragallapati; Ravikanth Manyam
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec
View more
  2 in total

1.  GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives.

Authors:  Gerardo Cazzato; Anna Colagrande; Antonietta Cimmino; Caterina Abbatepaolo; Emilio Bellitti; Paolo Romita; Lucia Lospalluti; Caterina Foti; Francesca Arezzo; Vera Loizzi; Teresa Lettini; Sara Sablone; Leonardo Resta; Gennaro Cormio; Giuseppe Ingravallo; Roberta Rossi
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

Review 2.  New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes.

Authors:  Lingwen Gu; Guofeng Ma; Cui Li; Jing Lin; Guiqiu Zhao
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.